A report from the Federal Trade Commission is warning state lawmakers about the dangers of shielding hospital mergers from federal antitrust scrutiny in exchange for prolonged state oversight.
The report released on Monday compiles research that shows these arrangements, often called Certificates of Public Advantage, result in higher prices, lower quality of care and lower wage growth for employees.
Despite hospitals’ claims about the benefits of COPAs, “we are not aware of any proven benefits of COPAs,” FTC Director of Policy Planning Elizabeth Wilkins said in a statement. “We urge state lawmakers to consult local health insurers, employers, and workers regarding the potential impact of COPA legislation.”
COPAs rarely make good on their promises, the FTC said, and lawmakers should remain skeptical of these arrangements.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Extends Support for Farms and Fisheries Amid Market Disruptions
May 5, 2024 by
CPI
Sony and Apollo Bid $26 Billion for Paramount Acquisition
May 5, 2024 by
CPI
Goldman Sachs Resolves Decade-Old Metal-Rigging Class Action Lawsuit
May 5, 2024 by
CPI
Italian Antitrust Ruling Puts Halt on Intesa Sanpaolo’s Fintech Ambitions
May 5, 2024 by
CPI
Google Antitrust Case: Closing Arguments Conclude
May 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI